Patent Yard Sign in
Canadian application, no grantCanada

Biallelic markers

CA 2324869 A1 · Owner: Whitehead Institute For Biomedical Research · Inventors: Hudson, Thomas; Lander, Eric S.; Wang, David

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides nucleic acid segments of the human genome including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking these sites are also provided. The nucleic acids primers and probes , are used in applications such as forensics paternity testing, medicine and , genetic analysis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 30, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 30, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 30, 1999
GrantedNo grant recorded
Term endedMarch 30, 2019
Patent numberCA 2324869 A1
Classification (IPC)—

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedMarch 30, 1999Term endedMarch 30, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.